Record_number,Author,Year,Journal,Group_ID,Group,Age_lower,Age_upper,Total_doses,Dosage,Days_between_doses,Days_lower,Days_upper,Immunity_type,Target,Assay_or_measurement,CD4,CD8,Specific_immunity_type,Immunity_measurement_unit,Display_item,Mean_1,Mean_2,SE_1,SE_2,N_1,N_2,Delta_mean,Delta_sd,Delta_transform,Ref_baseline,Ref_baseline_test,Th1_biased,t_cell_type,Delta_lower,Delta_upper,Comp_group,Ref_group,Concentration_comp_group,Concentration_ref_group,Vaccine,Vaccine_type,Concentration_ratio
42,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",18,55,2,2,14,28,28,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per million PBMC,Figure S4A,1.611099,1.7768,0.2122944,0.1287424,13,14,-0.16570099999999988,0.248281126606756,Log10,Higher,Significant,Yes,Any,-0.6523320081492416,0.3209300081492419,A1,A2,3,6,BBV152,Inactivated,0.5
42,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",18,55,2,2,14,28,28,Cellular,Antigen,ELISpot,Yes,NA,IFN-gamma,Percentage,Figure S4C,0.51375,0.69,0.08778906,0.09067209,13,14,-0.1762499999999999,0.12620755508546902,"NA",Higher,Significant,Yes,CD4,-0.4236168079675192,0.07111680796751937,A1,A2,3,6,BBV152,Inactivated,0.5
42,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",18,55,2,2,14,28,28,Cellular,Antigen,ELISpot,NA,Yes,IFN-gamma,Percentage,Figure S4D,0.05375,0.16,0.0232945,0.1137039,13,14,-0.10625000000000001,0.11606554443701196,"NA",Higher,NS,Yes,CD8,-0.3337384670965434,0.12123846709654343,A1,A2,3,6,BBV152,Inactivated,0.5
316,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",12,65,2,2,28,42,42,Cellular,Antigen,Luminex multiplex assay,Yes,NA,IFN-gamma,pg per ml,Table S2,1167.2,1082.5,368.01,495.71,29,29,84.70000000000005,617.3813766222626,"NA","NA","NA",Yes,CD4,-1125.3674981796346,1294.7674981796347,A1,A2,3,6,BBV152,Inactivated,0.5
316,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",12,65,2,2,28,42,42,Cellular,Antigen,Luminex multiplex assay,Yes,NA,TNF-alpha,pg per ml,Table S2,4577.1,3612.7,286.79,354.4,29,29,964.4000000000005,455.90334951610083,"NA","NA","NA",Yes,CD4,70.8294349484429,1857.9705650515582,A1,A2,3,6,BBV152,Inactivated,0.5
316,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",12,65,2,2,28,42,42,Cellular,Antigen,Luminex multiplex assay,Yes,NA,IL-2,pg per ml,Table S2,42.13,28.1,5.68,2.653,29,29,14.030000000000001,6.269035731274787,"NA","NA","NA",Yes,CD4,1.742689966701418,26.317310033298583,A1,A2,3,6,BBV152,Inactivated,0.5
316,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",12,65,2,2,28,42,42,Cellular,Antigen,Luminex multiplex assay,Yes,NA,IL-5,pg per ml,Table S2,33.4,30.9,2.14,1.888,29,29,2.5,2.853794666755126,"NA","NA","NA",Yes,CD4,-3.093437546840047,8.093437546840047,A1,A2,3,6,BBV152,Inactivated,0.5
316,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",12,65,2,2,28,42,42,Cellular,Antigen,Luminex multiplex assay,Yes,NA,IL-10,pg per ml,Table S2,27.3,72.2,2.959,9.337,29,29,-44.900000000000006,9.794654154180227,"NA","NA","NA",Yes,CD4,-64.09752214219326,-25.70247785780676,A1,A2,3,6,BBV152,Inactivated,0.5
316,"Ella, R",2021,Lancet ID,A1/A2,"Low-dose, Algel-IMDG to High-dose, Algel-IMDG",12,65,2,2,28,42,42,Cellular,Antigen,Luminex multiplex assay,Yes,NA,IL-13,pg per ml,Table S2,20.1,16.3,2.806122,3.520408,29,29,3.8000000000000007,4.501954371753228,"NA","NA","NA",Yes,CD4,-5.023830568636326,12.623830568636327,A1,A2,3,6,BBV152,Inactivated,0.5
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th1,Percentage,Table S6c,0.264,0.336,0.0857,0.0714,10,10,-0.07200000000000001,0.11154573053236955,"NA",Higher,Significant,Yes,CD4,-0.2906296318434443,0.1466296318434443,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th1,Percentage,Table S6c,0.095,0.317,0.0173,0.079,10,10,-0.222,0.08087205945195164,"NA",Higher,Significant,Yes,CD4,-0.38050923652582525,-0.06349076347417479,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IFN-gamma,Percentage,Table S6c,0.108,0.148,0.02346939,0.023979592,10,10,-0.039999999999999994,0.03355343647763317,"NA",Higher,Significant,Yes,CD4,-0.105764735496161,0.025764735496161012,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IFN-gamma,Percentage,Table S6c,0.031,0.164,0.007653061,0.044387755,10,10,-0.133,0.04504267017628669,"NA",Higher,Significant,Yes,CD4,-0.2212836335455219,-0.0447163664544781,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-2,Percentage,Table S6c,0.204,0.224,0.06632653,0.05204082,10,10,-0.020000000000000018,0.08430572654400945,"NA",Higher,Significant,Yes,CD4,-0.18523922402625853,0.1452392240262585,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-2,Percentage,Table S6c,0.065,0.214,0.01173469,0.05306122,10,10,-0.149,0.05434331621537739,"NA",Higher,Significant,Yes,CD4,-0.25551289978213965,-0.04248710021786031,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,TNF-alpha,Percentage,Table S6c,0.224,0.296,0.07091837,0.06122449,10,10,-0.07199999999999998,0.09369019894960731,"NA",Higher,Significant,Yes,CD4,-0.2556327899412303,0.11163278994123035,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,TNF-alpha,Percentage,Table S6c,0.085,0.295,0.01785714,0.07653061,10,10,-0.20999999999999996,0.07858633288270742,"NA",Higher,Significant,Yes,CD4,-0.3640292124501065,-0.05597078754989343,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th2,Percentage,Table S7c,0.022,0.029,0.005102041,0.009693878,10,10,-0.007000000000000003,0.010954546683663592,"NA",Minimal,NS,Yes,CD4,-0.028470911499980642,0.014470911499980636,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th2,Percentage,Table S7c,0.015,0.023,0.003061224,0.006122449,10,10,-0.008,0.006845105852781022,"NA",Minimal,NS,Yes,CD4,-0.0214164074714508,0.005416407471450802,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-13,Percentage,Table S7c,0.019,0.018,0.006122449,0.006632653,10,10,0.0010000000000000009,0.009026431608116798,"NA",Minimal,NS,Yes,CD4,-0.016691805951908924,0.018691805951908926,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-13,Percentage,Table S7c,0.013,0.015,0.003061224,0.003571429,10,10,-0.002,0.004703849219545308,"NA",Minimal,NS,Yes,CD4,-0.011219544470308804,0.007219544470308804,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-4,Percentage,Table S7c,0.01,0.021,0.002040816,0.006632653,10,10,-0.011000000000000001,0.0069395256152178725,"NA",Minimal,NS,Yes,CD4,-0.02460147020582703,0.002601470205827029,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-4,Percentage,Table S7c,0.005,0.015,0.002040816,0.004081633,10,10,-0.009999999999999998,0.004563404199996424,"NA",Minimal,NS,Yes,CD4,-0.01894427223199299,-0.001055727768007008,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,Any CD8,Percentage,Table S8c,0.089,0.075,0.05816327,0.02244898,10,10,0.013999999999999999,0.06234518971126241,"NA",Minimal,NS,Yes,CD8,-0.10819657183407433,0.13619657183407433,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,Any CD8,Percentage,Table S8c,0.035,0.128,0.01530612,0.07244898,10,10,-0.093,0.07404817359324131,"NA",Minimal,NS,Yes,CD8,-0.23813442024275297,0.05213442024275297,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IFN-gamma,Percentage,Table S8c,0.088,0.058,0.05510204,0.01734694,10,10,0.029999999999999992,0.05776808062871052,"NA",Minimal,NS,Yes,CD8,-0.08322543803227261,0.1432254380322726,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IFN-gamma,Percentage,Table S8c,0.031,0.126,0.0122449,0.07040816,10,10,-0.095,0.071465002417936,"NA",Minimal,NS,Yes,CD8,-0.23507140473915455,0.04507140473915455,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IL-2,Percentage,Table S8c,0.047,0.029,0.030102041,0.004591837,10,10,0.018,0.030450251877451685,"NA",Minimal,NS,Yes,CD8,-0.04168249367980531,0.0776824936798053,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IL-2,Percentage,Table S8c,0.008,0.056,0.013265306,0.029081633,10,10,-0.048,0.03196419436213472,"NA",Minimal,NS,Yes,CD8,-0.11064982094978405,0.014649820949784051,A2,A4,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A1/A3,"Low-dose, 56to70 to High-dose, 56to70",56,70,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,TNF-alpha,Percentage,Table S8c,0.061,0.036,0.04744898,0.017346939,10,10,0.025,0.050520510643798144,"NA",Minimal,NS,Yes,CD8,-0.07402020086184435,0.12402020086184437,A1,A3,25,100,mRNA-1273,mRNA,0.25
12,"Anderson, E",2020,NEJM,A2/A4,"Low-dose, 71to High-dose, 71",71,100,2,2,28,42,42,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,TNF-alpha,Percentage,Table S8c,0.018,0.087,0.006632653,0.053571429,10,10,-0.06899999999999999,0.05398046026962395,"NA",Minimal,NS,Yes,CD8,-0.1748017021284629,0.03680170212846294,A2,A4,25,100,mRNA-1273,mRNA,0.25
312,"Pan, H",2021,Chinese Medical Journal,A2/A1,"High dose, phase 1 to Low dose, phase 1",18,59,2,2,14,42,42,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per 200000PBMC,Figure 4A,1.10305,0.9864036,0.1008281,0.07115829,24,23,0.116646,0.1645819,Log10,Lower,NS,Yes,Any,-0.20593452399999998,0.43922652399999995,A2,A1,10,5,KCONVAC,Inactivated,2
926,"Hsieh, S",2021,EClinicalMedicine,A1/A2,Low dose to medium dose,20,49,2,2,28,57,57,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per million PBMC,Figure 4A,160.8,86.53,72.551306,45.876779,15,15,74.27,85.83922,"NA",Higher,Significant,Yes,Any,-93.97487120000001,242.51487120000002,A1,A2,5,15,MVC-COV1901,Recombinant,0.3333333333333333
926,"Hsieh, S",2021,EClinicalMedicine,A3/A2,High dose to medium dose,20,49,2,2,28,57,57,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per million PBMC,Figure 4A,95.99,86.53,51.456457,45.876779,15,15,9.46,68.93799,"NA",Higher,Significant,Yes,Any,-125.6584604,144.5784604,A3,A2,25,15,MVC-COV1901,Recombinant,1.6666666666666667
926,"Hsieh, S",2021,EClinicalMedicine,A1/A2,Low dose to medium dose,20,49,2,2,28,57,57,Cellular,Antigen,ELISpot,NA,NA,IL-4,SFU per million PBMC,Figure 4B,25.09,17.66,14.149299,8.745196,15,15,7.43,16.633734255115925,"NA",Higher,Significant,Yes,Any,-25.172119140027213,40.03211914002721,A1,A2,5,15,MVC-COV1901,Recombinant,0.3333333333333333
926,"Hsieh, S",2021,EClinicalMedicine,A3/A2,High dose to medium dose,20,49,2,2,28,57,57,Cellular,Antigen,ELISpot,NA,NA,IL-4,SFU per million PBMC,Figure 4B,31.17,17.66,17.286416,8.745196,15,15,13.510000000000002,19.372625821077328,"NA",Higher,Significant,Yes,Any,-24.46034660931156,51.48034660931157,A3,A2,25,15,MVC-COV1901,Recombinant,1.6666666666666667
118,"Meng, F",2021,Signal Transduction and Targeted Therapy,A1/B1,"2 low dose to 3 high dose in adult, phase 1",18,55,2,2,28,42,42,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 2A,25.2,39.9,6.377551,6.530612,24,24,-14.7,9.12809124911364,"NA",Higher,Significant,"NA",Any,-32.59105884826273,3.1910588482627347,A1,B1,20,40,Sf9 cells,Recombinant,0.5
118,"Meng, F",2021,Signal Transduction and Targeted Therapy,A3/B2,"2 low dose to 3 high dose in elderly, phase 1",56,100,2,2,28,42,42,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 2B,15.5,4.6,4.183673,1.581633,24,24,10.9,4.472659468103736,"NA",Higher,Significant,"NA",Any,2.133587442516678,19.666412557483323,A3,B2,20,40,Sf9 cells,Recombinant,0.5
118,"Meng, F",2021,Signal Transduction and Targeted Therapy,A1/B1,"2 low dose to 3 high dose in adult, phase 1",18,55,2,2,28,56,56,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 2A,10.27,10.69,2.081633,2.632653,24,24,-0.41999999999999993,3.356196919892812,"NA",Higher,Significant,"NA",Any,-6.998145962989911,6.158145962989911,A1,B1,20,40,Sf9 cells,Recombinant,0.5
118,"Meng, F",2021,Signal Transduction and Targeted Therapy,A3/B2,"2 low dose to 3 high dose in elderly, phase 1",56,100,2,2,28,56,56,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 2B,8.47,11.99,1.219388,4.346939,24,24,-3.5199999999999996,4.514729866145371,"NA",Higher,Significant,"NA",Any,-12.368870537644927,5.328870537644928,A3,B2,20,40,Sf9 cells,Recombinant,0.5
346,"Yang, S",2021,Lancet ID,A2/A1,"50ug, 3 doses, phase 1 to 25ug, 3 doses, phase 1",18,59,3,3,30,74,74,Cellular,Antigen,ELISpot,NA,NA,IFN-gamma,SFU per 300000 PBMC,Figure 3,0.8188854145940099,0.8122446968003693,0.1738172,0.2273846,20,20,0.006640717793640616,0.2862100196237022,Log10,Higher,NS,Both,Any,-0.5543309206688156,0.5676123562560969,A2,A1,50,25,ZF2001,Recombinant,2
346,"Yang, S",2021,Lancet ID,A2/A1,"50ug, 3 doses, phase 1 to 25ug, 3 doses, phase 1",18,59,3,3,30,74,74,Cellular,Antigen,ELISpot,NA,NA,IL-2,SFU per 300000 PBMC,Figure 3,1.498861688992884,1.360971883725936,0.1101037,0.1054898,20,20,0.13788980526694816,0.15248253230363798,Log10,Higher,Significant,Both,Any,-0.16097595804818227,0.4367555685820786,A2,A1,50,25,ZF2001,Recombinant,2
346,"Yang, S",2021,Lancet ID,A2/A1,"50ug, 3 doses, phase 1 to 25ug, 3 doses, phase 1",18,59,3,3,30,74,74,Cellular,Antigen,ELISpot,NA,NA,IL-4,SFU per 300000 PBMC,Figure 3,0.8739015978644614,0.5465426634781311,0.1195536,0.1261468,20,20,0.32735893438633035,0.17379895978745097,Log10,Higher,Significant,Both,Any,-0.013287026797073553,0.6680048955697342,A2,A1,50,25,ZF2001,Recombinant,2
346,"Yang, S",2021,Lancet ID,A2/A1,"50ug, 3 doses, phase 1 to 25ug, 3 doses, phase 1",18,59,3,3,30,74,74,Cellular,Antigen,ELISpot,NA,NA,IL-5,SFU per 300000 PBMC,Figure 3,1.4717316514800511,1.6086329894900369,0.1722582,0.1137657,20,20,-0.13690133800998572,0.206435273060904,Log10,Higher,Significant,Both,Any,-0.5415144732093575,0.26771179718938615,A2,A1,50,25,ZF2001,Recombinant,2
218,"Li, J",2021,Nat Med,A1/A2,"10ug, adult to 30ug, adult",18,55,2,2,21,28,28,Cellular,S1,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 3A,1.55685,1.701341,0.108803,0.1114295,24,24,-0.1444915,0.2077027,Log10,Higher,Significant,"NA",Any,-0.551588792,0.262605792,A1,A2,10,30,BNT162b1,mRNA,0.3333333333333333
218,"Li, J",2021,Nat Med,A3/A4,"10ug, elderly to 30ug, elderly",56,85,2,2,21,28,28,Cellular,S1,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 3B,1.581437,1.663454,0.1404984,0.1194722,23,23,-0.0820172,0.2416066,Log10,Higher,Significant,"NA",Any,-0.5555661359999999,0.39153173599999996,A3,A4,10,30,BNT162b1,mRNA,0.3333333333333333
9,"Sahin, U",2020,Nature,A1/A3,1ug to 30ug,18,55,2,2,21,28,28,Cellular,RBD,ELISpot,Yes,NA,IFN-gamma,SFU per million PBMC,Figure 3A,2.4533249,2.7486066,0.2931821,0.1004873,11,10,-0.2952817,0.2827444,Log10,Higher,Significant,Yes,CD4,-0.849460724,0.258897324,A1,A3,1,30,BNT162b1,mRNA,0.03333333333333333
9,"Sahin, U",2020,Nature,A2/A3,10ug to 30ug,18,55,2,2,21,28,28,Cellular,RBD,ELISpot,Yes,NA,IFN-gamma,SFU per million PBMC,Figure 3A,2.7242876,2.7486066,0.1309309,0.1004873,11,10,-0.024319,0.1473709,Log10,Higher,Significant,Yes,CD4,-0.31316596399999996,0.264527964,A2,A3,10,30,BNT162b1,mRNA,0.3333333333333333
9,"Sahin, U",2020,Nature,A4/A3,50ug to 30ug,18,55,2,2,21,28,28,Cellular,RBD,ELISpot,Yes,NA,IFN-gamma,SFU per million PBMC,Figure 3A,2.966292,2.7486066,0.166322,0.1004873,10,10,0.2176854,0.1687954,Log10,Higher,Significant,Yes,CD4,-0.113153584,0.548524384,A4,A3,50,30,BNT162b1,mRNA,1.6666666666666667
9,"Sahin, U",2020,Nature,A1/A3,1ug to 30ug,18,55,2,2,21,28,28,Cellular,RBD,ELISpot,NA,Yes,IFN-gamma,SFU per million PBMC,Figure 3A,2.4212495,2.1814972,0.2317439,0.2276713,11,10,0.2397523,0.2871712,Log10,Higher,Significant,Yes,CD8,-0.323103252,0.8026078520000001,A1,A3,1,30,BNT162b1,mRNA,0.03333333333333333
9,"Sahin, U",2020,Nature,A2/A3,10ug to 30ug,18,55,2,2,21,28,28,Cellular,RBD,ELISpot,NA,Yes,IFN-gamma,SFU per million PBMC,Figure 3A,2.2770736,2.1814972,0.2487814,0.2276713,11,10,0.0955764,0.2989896,Log10,Higher,Significant,Yes,CD8,-0.49044321600000007,0.6815960160000001,A2,A3,10,30,BNT162b1,mRNA,0.3333333333333333
9,"Sahin, U",2020,Nature,A4/A3,50ug to 30ug,18,55,2,2,21,28,28,Cellular,RBD,ELISpot,NA,Yes,IFN-gamma,SFU per million PBMC,Figure 3A,2.815021,2.1814972,0.3037,0.2276713,10,10,0.6335238,0.3795628,Log10,Higher,Significant,Yes,CD8,-0.110419288,1.3774668879999998,A4,A3,50,30,BNT162b1,mRNA,1.6666666666666667
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th1,Percentage,Figure S9,0.1024436,0.1933333,0.01913657,0.02971817,13,14,-0.0908897,0.03534654,"NA",Higher,Significant,Yes,CD4,-0.16016891840000003,-0.021610481599999995,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IFN-gamma,Percentage,Figure S9,0.06935919,0.08333333,0.04497112,0.01188726,13,14,-0.01397414,0.04651568,"NA",Higher,Significant,Yes,CD4,-0.10514487279999998,0.07719659279999999,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-2,Percentage,Figure S9,0.06306305,0.11053189,0.01054974,0.01774907,13,14,-0.04746884,0.02064767,"NA",Higher,Significant,Yes,CD4,-0.0879382732,-0.0069994067999999965,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,TNF-alpha,Percentage,Figure S9,0.08715984,0.18,0.01614103,0.02773695,13,14,-0.09284016,0.0320916,"NA",Higher,Significant,Yes,CD4,-0.15573969599999998,-0.029940624000000013,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th2,Percentage,Figure S9,0.01530143,0.00776589,0.00301827,0.003650092,13,14,0.007535539,0.004736362,"NA",Minimal,NS,Yes,CD4,-0.00174773052,0.01681880852,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-4,Percentage,Figure S9,0.01530143,0.010619684,0.00301827,0.002754177,13,14,0.004681745,0.004086006,"NA",Minimal,NS,Yes,CD4,-0.0033268267599999993,0.01269031676,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-13,Percentage,Figure S9,0.010619684,0.010619684,0.002858144,0.002754177,13,14,0,0.003969191,"NA",Minimal,NS,Yes,CD4,-0.007779614360000001,0.007779614360000001,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,Any CD8,Percentage,Figure S11,0.02,0.036666667,0.004111999,0.009906053,13,14,-0.01666667,0.0107256,"NA",Minimal,NS,Yes,CD8,-0.037688846,0.004355505999999999,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IFN-gamma,Percentage,Figure S11,0.01,0.033333333,0.004111999,0.007924842,13,14,-0.02333333,0.008928139,"NA",Minimal,NS,Yes,CD8,-0.04083248244,-0.005834177560000001,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IL-2,Percentage,Figure S11,0.02230015,0.023010352,0.008757919,0.009105776,13,14,-7.102025e-4,0.01263393,"NA",Minimal,NS,Yes,CD8,-0.0254727053,0.0240523003,A1,A2,25,100,mRNA-1273,mRNA,0.25
19,"Jackson, L",2020,NEJM,A1/A2,25ug to 100ug,18,55,2,2,28,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,TNF-alpha,Percentage,Figure S11,0.01,0.04683127,0.004111999,0.04107005,13,14,-0.03683127,0.04127538,"NA",Minimal,NS,Yes,CD8,-0.11773101479999999,0.04406847479999999,A1,A2,25,100,mRNA-1273,mRNA,0.25
16,"Sadoff, J",2021,NEJM,A2/A1,"High dose, 1 dose, adult to low dose, 1 dose, adult",18,55,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th1,Percentage,Figure 3A,0.121167,0.08,0.008011324,0.005241791,72,72,0.041167,0.009573802,"NA",Higher,Significant,Yes,CD4,0.022402348080000002,0.05993165192,A2,A1,10,5,Ad26.COV2.S,Vector,2
16,"Sadoff, J",2021,NEJM,A4/A3,"High dose, 1 dose, elderly to low dose, 1 dose, elderly",65,100,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th1,Percentage,Figure 3A,0.1211668,0.1219563,0.009250546,0.01540985,54,53,-0.00078950000000000005,0.0179732,"NA",Higher,Significant,Yes,CD4,-0.036016972,0.034437972000000004,A4,A3,10,5,Ad26.COV2.S,Vector,2
16,"Sadoff, J",2021,NEJM,A2/A1,"High dose, 1 dose, adult to low dose, 1 dose, adult",18,55,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,Any CD8,Percentage,Figure 3C,0.1611775,0.2017422,0.02662076,0.06221734,72,72,-0.0405647,0.0676732,"NA",Higher,Significant,Yes,CD8,-0.17320417200000002,0.092074772,A2,A1,10,5,Ad26.COV2.S,Vector,2
16,"Sadoff, J",2021,NEJM,A4/A3,"High dose, 1 dose, elderly to low dose, 1 dose, elderly",65,100,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,Any CD8,Percentage,Figure 3C,0.08444412,0.1343688,0.01190458,0.1126285,54,53,-0.04992468,0.1132559,"NA",Higher,Significant,Yes,CD8,-0.271906244,0.17205688400000002,A4,A3,10,5,Ad26.COV2.S,Vector,2
3,"Zhu, F",2020,Lancet,A1/A2,High dose to low dose,18,100,1,1,0,28,28,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 3A,1.046101,1.091742,0.03257564,0.03968636,253,129,-0.045641,0.05134374,Log10,Higher,Significant,"NA",Any,-0.1462747304,0.054992730399999995,A1,A2,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 1A,1.60399678,1.31016031,0.04075973,0.05218778,36,36,0.2938365,0.06621873,Log10,Higher,Significant,"NA",Any,0.1640477892,0.42362521080000004,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 1A,1.73822168,1.31016031,0.04278096,0.05218778,36,36,0.4280614,0.06748166,Log10,Higher,Significant,"NA",Any,0.2957973464,0.5603254536,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 1A,1.22671371,1.13605889,0.03584302,0.05156049,36,36,0.09065481,0.06279495,Log10,Higher,Significant,"NA",Any,-0.032423292000000006,0.213732912,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per 100000 PBMC,Figure 1A,1.34917913,1.13605889,0.03501442,0.05156049,36,36,0.2131202,0.2131202,Log10,Higher,Significant,"NA",Any,-0.20459539200000001,0.6308357920000001,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IFN-gamma,Percentage,Figure 2A,0.217790938492912,0.184916324322534,0.0190990166332397,0.0181107360729315,36,36,0.032874614170378014,0.026320547058527276,"NA",Higher,Significant,"NA",CD4,-0.018713658064335448,0.08446288640509148,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IFN-gamma,Percentage,Figure 2A,0.289403177435625,0.184916324322534,0.0268786711044382,0.0181107360729315,36,36,0.104486853113091,0.03241082722554214,"NA",Higher,Significant,"NA",CD4,0.04096163175102842,0.1680120744751536,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IFN-gamma,Percentage,Figure 2A,0.150202583300547,0.130429091549209,0.00948648832121767,0.0112672680003495,36,36,0.019773491751337996,0.014729045755251732,"NA",Higher,Significant,"NA",CD4,-0.0090954379289554,0.04864242143163139,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IFN-gamma,Percentage,Figure 2A,0.150202583300547,0.130429091549209,0.00948648832121767,0.0112672680003495,36,36,0.019773491751337996,0.014729045755251732,"NA",Higher,Significant,"NA",CD4,-0.0090954379289554,0.04864242143163139,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,TNF-alpha,Percentage,Figure 2A,0.0595345656124388,0.030602984899327,0.00678483537669154,0.00362711631694624,36,36,0.028931580713111797,0.007693501404787205,"NA",Higher,Significant,"NA",CD4,0.013852317959728876,0.04401084346649472,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,TNF-alpha,Percentage,Figure 2A,0.0993182637335584,0.030602984899327,0.00888536564323975,0.00362711631694624,36,36,0.0687152788342314,0.009597171218162307,"NA",Higher,Significant,"NA",CD4,0.04990482324663327,0.08752573442182952,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,TNF-alpha,Percentage,Figure 2A,0.0568777741791935,0.0568777741791935,0.00428144968233233,0.00428144968233233,36,36,0,0.0060548842073723606,"NA",Higher,Significant,"NA",CD4,-0.011867573046449826,0.011867573046449826,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,TNF-alpha,Percentage,Figure 2A,0.0566666666666667,0.0568777741791935,0.003706505546264,0.00428144968233233,36,36,-2.1110751252680082e-4,0.005662949297568309,"NA",Higher,Significant,"NA",CD4,-0.011310488135760686,0.010888273110707085,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-2,Percentage,Figure 2A,0.19,0.185104971415201,0.014826022185056,0.0162452535328907,36,36,0.0048950285847990105,0.02199361716907136,"NA",Higher,Significant,"NA",CD4,-0.038212461066580855,0.048002518236178876,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-2,Percentage,Figure 2A,0.220474837943631,0.185104971415201,0.0158255226194092,0.0162452535328907,36,36,0.03536986652843002,0.02267940538297532,"NA",Higher,Significant,"NA",CD4,-0.009081768022201606,0.07982150107906165,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-2,Percentage,Figure 2A,0.150202583300547,0.14,0.00948648832121767,0.00741301109252801,36,36,0.010202583300546991,0.01203936020420282,"NA",Higher,Significant,"NA",CD4,-0.013394562699690537,0.03379972930078452,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,IL-2,Percentage,Figure 2A,0.146414591455033,0.14,0.0114176100601468,0.00741301109252801,36,36,0.006414591455032981,0.013613028793898467,"NA",Higher,Significant,"NA",CD4,-0.020266944981008013,0.033096127891073975,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IFN-gamma,Percentage,Figure 2B,0.06,0.105757973943529,0.00741301109252801,0.0194042216292204,36,36,-0.045757973943529,0.020772013635992254,"NA",Higher,Significant,"NA",CD8,-0.08647112067007381,-0.005044827216984182,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IFN-gamma,Percentage,Figure 2B,0.104599127168914,0.105757973943529,0.00879843211048704,0.0194042216292204,36,36,-0.0011588467746150022,0.021305779137096918,"NA",Higher,Significant,"NA",CD8,-0.04291817388332496,0.040600480334094954,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IFN-gamma,Percentage,Figure 2B,0.121167579879679,0.0998730343425963,0.0113305875761841,0.0131916329476432,36,36,0.021294545537082696,0.017389692195289803,"NA",Higher,Significant,"NA",CD8,-0.012789251165685321,0.05537834223985071,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IFN-gamma,Percentage,Figure 2B,0.124092509083474,0.0998730343425963,0.0137594575035149,0.0131916329476432,36,36,0.024219474740877697,0.01906152802417419,"NA",Higher,Significant,"NA",CD8,-0.013141120186503714,0.06158006966825911,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,TNF-alpha,Percentage,Figure 2B,0.00666666666666667,0.0106196841320978,0.00123550184875467,0.00171753086112479,36,36,-0.003953017465431131,0.00211574504068715,"NA",Higher,Significant,"NA",CD8,-0.008099877745177946,1.9384281431568309e-4,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,TNF-alpha,Percentage,Figure 2B,0.015301494627576,0.0106196841320978,0.00181355772506174,0.00171753086112479,36,36,0.0046818104954782,0.0024977797903432512,"NA",Higher,Significant,"NA",CD8,-2.1383789359457218e-4,0.009577458884550971,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,TNF-alpha,Percentage,Figure 2B,0.0106196841320978,0.0106196841320978,0.00171753086112479,0.00171753086112479,36,36,0,0.002428955437597019,"NA",Higher,Significant,"NA",CD8,-0.004760752657690157,0.004760752657690157,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,TNF-alpha,Percentage,Figure 2B,0.015301494627576,0.0106196841320978,0.00181355772506174,0.00171753086112479,36,36,0.0046818104954782,0.0024977797903432512,"NA",Higher,Significant,"NA",CD8,-2.1383789359457218e-4,0.009577458884550971,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IL-2,Percentage,Figure 2B,0.00666666666666667,0.015301494627576,0.00123550184875467,0.00181355772506174,36,36,-0.00863482796090933,0.0021944148286974644,"NA",Higher,Significant,"NA",CD8,-0.012935881025156361,-0.0043337748966623,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IL-2,Percentage,Figure 2B,0.015301494627576,0.015301494627576,0.00181355772506174,0.00181355772506174,36,36,0,0.0025647579309288093,"NA",Higher,Significant,"NA",CD8,-0.005026925544620466,0.005026925544620466,A3,A1,15,5,Ad5-nCoV,Vector,3
17,"Zhu, F",2020,Lancet,A2/A1,Middle dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IL-2,Percentage,Figure 2B,0.00666666666666667,0.00666666666666667,0.00123550184875467,0.00123550184875467,36,36,0,0.0017472634708458868,"NA",Higher,Significant,"NA",CD8,-0.003424636402857938,0.003424636402857938,A2,A1,10,5,Ad5-nCoV,Vector,2
17,"Zhu, F",2020,Lancet,A3/A1,High dose to low dose,18,60,1,1,0,28,28,Cellular,Spike,Intracellular cytokine-staining assay,NA,Yes,IL-2,Percentage,Figure 2B,0.00776338847877589,0.00666666666666667,0.00227584399719563,0.00123550184875467,36,36,0.0010967218121092203,0.0025895811857996635,"NA",Higher,Significant,"NA",CD8,-0.00397885731205812,0.006172300936276561,A3,A1,15,5,Ad5-nCoV,Vector,3
2431,"Zhu, F",2021,CID,A1/A2,Middle dose to low dose,56,100,2,2,28,84,84,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per million PBMC,Figure 4,1.91037436,1.81241078,0.03968794,0.04779085,100,98,0.09796358000000005,0.06212163813975047,Log10,Higher,Significant,Yes,Any,-0.023794830753910867,0.21972199075391097,A1,A2,10,5,Ad5-nCoV,Vector,2
2431,"Zhu, F",2021,CID,A1/A2,Middle dose to low dose,56,100,2,2,28,84,84,Cellular,Spike,ELISpot,NA,NA,IL-2,SFU per million PBMC,Figure 4,1.54264486,1.47970825,0.03469814,0.03138137,100,98,0.06293660999999995,0.04678409240902831,Log10,Higher,Significant,Yes,Any,-0.028760211121695536,0.15463343112169542,A1,A2,10,5,Ad5-nCoV,Vector,2
2431,"Zhu, F",2021,CID,A1/A2,Middle dose to low dose,56,100,2,2,28,84,84,Cellular,Spike,ELISpot,NA,NA,IL-4,SFU per million PBMC,Figure 4,0.80450423,0.88184402,0.02477923,0.04098353,100,98,-0.07733978999999991,0.04789217024372355,Log10,Minimal,NS,Yes,Any,-0.17120844367769805,0.01652886367769825,A1,A2,10,5,Ad5-nCoV,Vector,2
2431,"Zhu, F",2021,CID,A1/A2,Middle dose to low dose,56,100,2,2,28,84,84,Cellular,Spike,ELISpot,NA,NA,IL-5,SFU per million PBMC,Figure 4,0.70930449,0.71903193,0.05699972,0.05579414,100,98,-0.009727440000000032,0.07976185892027592,Log10,Minimal,NS,Yes,Any,-0.1660606834837408,0.14660580348374075,A1,A2,10,5,Ad5-nCoV,Vector,2
2431,"Zhu, F",2021,CID,A1/A2,Middle dose to low dose,56,100,2,2,28,84,84,Cellular,Spike,ELISpot,NA,NA,IL-13,SFU per million PBMC,Figure 4,0.94744364,0.97811341,0.03492712,0.04297161,100,98,-0.03066976999999993,0.05537565329173553,Log10,Minimal,NS,Yes,Any,-0.13920605045180157,0.07786651045180171,A1,A2,10,5,Ad5-nCoV,Vector,2
837,Tebas,2021,EClinicalMedicine,A2/A1,2mg to 1mg,18,50,2,2,28,42,42,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per million PBMC,Figure 4A,6.2288636,4.6330495,0.3956689,0.5124171,19,18,1.5958141,0.7525963,Log2,Higher,Significant,Yes,Any,0.12072535200000001,3.070902848,A2,A1,2,1,INO-4880,DNA,2
303,"Ward, B",2021,Nat Med,A2/A1,"7.5ug, AS03 to 3.75ug, AS03",18,55,2,2,21,42,42,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per million PBMC,Figure 4A,2.4772243,2.77997539,0.1590523,0.08411602,20,20,-0.3027510900000001,0.17992537051769658,Log10,Higher,Significant,Both,Any,-0.6554048162146854,0.04990263621468516,A2,A1,7.5,3.75,Plant-based VLP,Virus-like particle,2
303,"Ward, B",2021,Nat Med,A3/A1,"15ug, AS03 to 3.75ug, AS03",18,55,2,2,21,42,42,Cellular,Spike,ELISpot,NA,NA,IFN-gamma,SFU per million PBMC,Figure 4A,2.42027,2.77997539,0.093292,0.08411602,20,20,-0.35970539000000024,0.1256140998639898,Log10,Higher,Significant,Both,Any,-0.6059090257334203,-0.11350175426658021,A3,A1,15,3.75,Plant-based VLP,Virus-like particle,4
303,"Ward, B",2021,Nat Med,A2/A1,"7.5ug, AS03 to 3.75ug, AS03",18,55,2,2,21,42,42,Cellular,Spike,ELISpot,NA,NA,IL-4,SFU per million PBMC,Figure 4B,2.40119908,2.62915412,0.06772353,0.07802619,20,20,-0.2279550399999999,0.10331777601931334,Log10,Higher,Significant,Both,Any,-0.43045788099785404,-0.025452199002145737,A2,A1,7.5,3.75,Plant-based VLP,Virus-like particle,2
303,"Ward, B",2021,Nat Med,A3/A1,"15ug, AS03 to 3.75ug, AS03",18,55,2,2,21,42,42,Cellular,Spike,ELISpot,NA,NA,IL-4,SFU per million PBMC,Figure 4B,2.39831485,2.62915412,0.04858512,0.07802619,20,20,-0.2308392699999997,0.09191626739228752,Log10,Higher,Significant,Both,Any,-0.4109951540888832,-0.05068338591111618,A3,A1,15,3.75,Plant-based VLP,Virus-like particle,4
16,"Sadoff, J",2021,NEJM,A2/A1,"High dose, 1 dose, adult to low dose, 1 dose, adult",18,55,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th2,Percentage,Figure 3A,0,0,0,0,72,72,0,0,"NA",Minimal,NS,Yes,CD4,0,0,A2,A1,10,5,Ad26.COV2.S,Vector,2
16,"Sadoff, J",2021,NEJM,A4/A3,"High dose, 1 dose, elderly to low dose, 1 dose, elderly",65,100,1,1,0,14,14,Cellular,Spike,Intracellular cytokine-staining assay,Yes,NA,Any Th2,Percentage,Figure 3A,0,0,0,0,54,53,0,0,"NA",Minimal,NS,Yes,CD4,0,0,A4,A3,10,5,Ad26.COV2.S,Vector,2
11,"Keech, C",2020,NEJM,A2/A1,Group D to Group C,18,59,2,2,21,35,35,Cellular,Antigen,intracellular cytokine staining,Yes,NA,IL-2,Percentage,Figure 5CD,0.8625,0.7575,0.5015538,0.2191793,4,4,0.1050000000000001,0.547353432293002,"NA",Higher,NS,Yes,CD4,-0.9678127272942839,1.1778127272942842,A2,A1,25,5,NVX-CoV2373,Recombinant,5
11,"Keech, C",2020,NEJM,A2/A1,Group D to Group C,18,59,2,2,21,35,35,Cellular,Antigen,intracellular cytokine staining,Yes,NA,TNF-alpha,Percentage,Figure 5CD,1.175,0.9325,0.6883495,0.2591774,4,4,0.24250000000000005,0.7355256343738197,"NA",Higher,NS,Yes,CD4,-1.1991302433726867,1.6841302433726866,A2,A1,25,5,NVX-CoV2373,Recombinant,5
11,"Keech, C",2020,NEJM,A2/A1,Group D to Group C,18,59,2,2,21,35,35,Cellular,Antigen,intracellular cytokine staining,Yes,NA,IFN-gamma,Percentage,Figure 5CD,0.165,0.2225,0.0764308,0.08778525,4,4,-0.057499999999999996,0.11639552098857799,"NA",Higher,NS,Yes,CD4,-0.28563522113761286,0.17063522113761284,A2,A1,25,5,NVX-CoV2373,Recombinant,5
11,"Keech, C",2020,NEJM,A2/A1,Group D to Group C,18,59,2,2,21,35,35,Cellular,Antigen,intracellular cytokine staining,Yes,NA,IL-5,Percentage,Figure 5CD,0.02,0.0275,0.02,0.0175,4,4,-0.0075,0.026575364531836624,"NA",Higher,NS,Yes,CD4,-0.05958771448239978,0.04458771448239978,A2,A1,25,5,NVX-CoV2373,Recombinant,5
11,"Keech, C",2020,NEJM,A2/A1,Group D to Group C,18,59,2,2,21,35,35,Cellular,Antigen,intracellular cytokine staining,Yes,NA,IL-13,Percentage,Figure 5CD,0.2675,0.2089408,0.28,0.09721111,4,4,0.058559200000000006,0.29639500654942236,"NA",Higher,NS,Yes,CD4,-0.5223750128368678,0.6394934128368679,A2,A1,25,5,NVX-CoV2373,Recombinant,5
